Brightlobe Limited
London, United Kingdom
Location status: Recruiting
NCT Number: NCT05780853
The aim of this study is to evaluate a novel tablet game-based neurodevelopmental assessment tool for young children aged 3 to 8 years old.
The study's main aims are: (1) to determine whether the novel tablet-game based assessment tool can accurately differentiate children's neurodevelopmental status based on their performance on the game and (2) assess the validity of the game-based neurodevelopment assessment tool.
The study aims to recruit 590 children who are 'typically' developing and/or have a diagnosed neurodevelopmental disorder including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Specific Learning Disorder, or a Communication Disorder.
All participants will complete the tablet game-based assessment which aims to assess a range of neuropsychological functions including attention, memory, language, motor, executive functions and social-emotional skills. Parents/carers of participants will also complete a demographic questionnaire and the Adaptive Behaviour System - Third Edition (ABAS-3), which is a questionnaire that assesses a child's development. Some participants will be re-tested on the tablet game-based assessment approximately 2 weeks after the first tablet game-based assessment to ensure the game's validity.
Interested in participating?
Request Info3 year–8 year
All sexes
Observational
London, United Kingdom
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
OR
All parents/caregivers and children must have a minimum level of English fluency required to complete the parent questionnaire and the game-based assessment.
Exclusion criteria
Tablet game-based assessment to assess neurodevelopmental profile.
A parent-reported child behavioural assessment questionnaire used to diagnose and classify various developmental, learning and behavioural disabilities and disorders.
Parent/carer and child's demographic data such as age, ethnicity, employment status, household income, medical history and education status.
Time frame: 16 months
Sensitivity and specificity of the tablet game-based assessment to accurately differentiate children's neurodevelopmental status.
Time frame: 16 months
Using exploratory factor analysis to explore the construct validity of the tablet game-based assessment.
Time frame: 16 months
Cronbach's alpha and omega statistic to assess internal consistency/reliability of the tool, which assesses the extent to which all the items in the game-based assessment measure the same concept or construct.
Time frame: 16 months
Known-group and predictive validity will both be assessed through multiple logistic regression.
Time frame: 16 months
Performance on the tablet game-based assessment tool will be obtained from metadata and psychometric data obtained from the game-based assessment tool and device such as response time, correct/incorrect responses and gyroscope readings. Performance scores may be dichotomous, continuous and/or counts. Preliminary normative data for performance on the tablet game-based assessment tool will be defined through an exploratory factor analysis.
Time frame: 16 months
Parent and child acceptability of the tablet-game based assessment tool and device will be conducted by asking parents 3 brief questions to assess parental perception of acceptability (e.g. Having seen your child complete the game today, how do you think they found the experience?). Child acceptability will be accessed using a smileyometer scale (5 ratings) to rate how they felt about the game-based assessment. Children will also be asked 8 brief questions about their opinions on the game (e.g. What did you think about the game?).
Time frame: 16 months
Acceptable levels of test-retest reliability/stability using Intraclass Correlation Coefficient (ICC) at two different time points within 2 weeks.
Time frame: 16 months
Any adverse events occurring during the duration of the study will be recorded and reported at the end of the study. These will be recorded as the number of events with qualitative data about the nature of the event. These events will then be grouped into different types of risk, and how likely they would be to occur in any future use of the device.
Time frame: 16 months
Descriptive analyses of participant demographics (e.g., age, ethnicity, employment status, household income, medical history and education status)
Time frame: 16 months
Scores on the parent-reported questionnaire (ABAS-3)
Contact information is provided by the study sponsor or research team.
Brightlobe Limited
Industry
Evaluation of a Novel Game-based Neurodevelopmental Assessment for Young Children
Acronym: BRIGHTEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06086951
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Hong Kong
View Trial DetailsNCT05872737
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Hong Kong
View Trial DetailsNCT07439276
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Paris, France
View Trial DetailsNCT05467527
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Ngau Tau Kok, Kowloon, Hong Kong
View Trial Details